VTRS Investors Have Opportunity to Lead Viatris Inc. Securities Fraud Lawsuit
1. A class action lawsuit has been filed against Viatris for misleading investors. 2. The lawsuit cites inadequate disclosures regarding FDA inspection issues in India. 3. Investors may seek compensation without upfront costs through a contingency fee arrangement. 4. Claims include the inflation of stock prices due to undisclosed material facts. 5. The class period for the lawsuit spans August 2024 to February 2025.